1. Home
  2. WSR vs COLL Comparison

WSR vs COLL Comparison

Compare WSR & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Whitestone REIT

WSR

Whitestone REIT

SELL

Current Price

$18.96

Market Cap

974.9M

Sector

Real Estate

ML Signal

SELL

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$36.10

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSR
COLL
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
974.9M
1.1B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
WSR
COLL
Price
$18.96
$36.10
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$19.00
$51.40
AVG Volume (30 Days)
677.0K
424.2K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
3.01%
N/A
EPS Growth
31.94
N/A
EPS
0.08
0.40
Revenue
$160,859,000.00
$780,567,000.00
Revenue This Year
$2.77
$8.01
Revenue Next Year
$4.21
N/A
P/E Ratio
$237.00
$90.50
Revenue Growth
4.26
23.62
52 Week Low
$11.43
$29.19
52 Week High
$19.10
$50.79

Technical Indicators

Market Signals
Indicator
WSR
COLL
Relative Strength Index (RSI) 51.24 59.11
Support Level $18.90 $33.80
Resistance Level $19.01 $48.74
Average True Range (ATR) 0.03 1.35
MACD -0.03 0.30
Stochastic Oscillator 27.50 81.55

Price Performance

Historical Comparison
WSR
COLL

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) that owns and operates commercial properties in culturally diverse metropolitan markets. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business-friendly locations in and around Austin, Scottsdale, Dallas, Houston, Phoenix, Arizona, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: